| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0008 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |